Navigation Links
New Clinical Studies Presented at the American Society of Anesthesiologists Annual Meeting Show Benefits of Masimo Noninvasive Technologies: SpHb, PVI, RRa, and SEDLine
Date:10/19/2011

IRVINE, Calif., Oct. 19, 2011 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that over 25 new clinical studies evaluating Masimo noninvasive patient monitoring technologies were presented at the largest gathering of anesthesiologists in the world, the American Society of Anesthesiologists (ASA) Annual Meeting in Chicago, Illinois.  The following studies highlight the positive clinical outcomes and patient safety impact of Masimo's unique noninvasive measurement technologies, including: total hemoglobin (SpHb®), pleth variability index (PVI®), acoustic respiration rate (RRa™), and SEDLine® brain function monitoring.

SpHb® & PVI®Researchers Steven Frank, M.D., James Rothschild, M.D., and John Ulatowski, M.D., at Johns Hopkins Hospital in Maryland found that the combination of continuous SpHb and PVI monitoring "may improve the efficacy and safety of the intraoperative autologous normovolemic hemodilution (IAHD) blood conservation technique that helps avoid allogeneic blood transfusions." The study, conducted in patients undergoing major abdominal or orthopedic surgery, concluded that SpHb was advantageous in "eliminating the delay in intraoperative decision-making that occurs when Hb measurements are obtained by conventional laboratory testing" while PVI was a "useful index of intravascular volume during the significant fluid shifts that occurred with IAHD, with increasing PVI indicating hypovolemia and decreasing PVI indicating adequate fluid resuscitation and blood re-infusion." (1)

Two studies, conducted by the Long Beach Veterans Healthcare System in California, found that noninvasive SpHb measurements provided valuable clinical assessment information in remote, rural, and community settings.  Nitin Shah, M.D., and Kinj
'/>"/>

SOURCE Masimo Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Phreesia and SOAPware Integrate to Improve Clinical Data and Streamline Workflow at Medical Practices
2. ClinStar to Present on Clinical Trial Recruitment in the Emerging Regions of Russia and Eastern Europe
3. Nile Therapeutics Completes Dosing of Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide in Chronic Heart Failure Patients
4. Pacira Pharmaceuticals, Inc. Announces Key EXPAREL™ Data to be Presented at American College of Surgeons 97th Annual Clinical Congress
5. Takeda Initiates Phase 3 Clinical Trial Program in the United States, Latin America, and Europe for Investigational Type 2 Diabetes Therapy TAK-875
6. vRad Announces Clinical Trials Partnership With ICON Medical Imaging
7. ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis
8. Access Pharmaceuticals Updates MuGard Website with New Video Featuring Clinical Feedback and Manufacturing Footage
9. Renessa® Treatment for Stress Incontinence: Three Year Clinical Results Presented
10. Phase 1 / 2 Clinical Trial Results of KRX-0401 (Perifosine) Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma Published in the Journal of Clinical Oncology
11. Telik Announces Initiation of a Phase 2b Clinical Trial of Telintra® (Ezatiostat HCL) in Patients With Low to Intermediate-1 Risk Non-Deletion (5q) Myelodysplastic Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015 Jintian Pharmaceutical Group Limited ("Jintian Pharmaceutical" ... Jin Dongtao, chairman and executive director purchased 40,000,000 ordinary ... the existing entire issued share capital of the Company ... the total amount of approximately HK$113 million. Upon the ... increase from 45.17% to 47.17%. Mr. ...
(Date:4/1/2015)... 30, 2015 Research and Markets ( ... "An Introduction to the Medical Device Directives" conference ... detailed introduction to the European medical device legislation. It ... the involvement of Notified Bodies, how to choose one ... also cover the documentation necessary to apply for the ...
(Date:4/1/2015)... 2015  Philips Respironics, a division of Royal Philips ... Pico nasal mask is now available in ... obstructive sleep apnea (OSA). Designed to maximize comfort and effectiveness, ... pressure (CPAP) mask available on the market to treat OSA*. ... will be on display at Medtrade Spring (Booth ...
Breaking Medicine Technology:Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5An Introduction to the Medical Device Directives Training: London, UK - 13th, 14th, 15th of May 2015 2Philips Pico CPAP Nasal Mask Now Available in the United States 2Philips Pico CPAP Nasal Mask Now Available in the United States 3
... by FDA for long-term maintenance,treatment of COPD ... improved lung function,comparable to dry powder formoterol, ... profile --, NAPA, Calif., May 20, 2007 ... of the American Thoracic Society (ATS),demonstrate that ...
... Also Show Nebivolol Lowers Blood Pressure in ... 2007 /PRNewswire-FirstCall/ -- Forest,Laboratories, Inc. today presented ... pooled analysis of nebivolol, a selective beta,1-blocker ... U.S. Food and Drug Administration (FDA) for ...
Cached Medicine Technology:Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 2Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 3Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 4
(Date:4/1/2015)... (PRWEB) April 01, 2015 NTOCC today ... transitions of care tools that seek to improve care ... this program, NTOCC hopes to bring light to tools ... transitions of care across the healthcare industry through the ... that advance collaborative patient-care. Following that vision, the Knowledge ...
(Date:4/1/2015)... panel session will look at the need for insurance ... that can grow in a privacy-friendly manner, thus preventing ... This topic has taken on even greater relevance in ... aren’t as secure as the automobile industry thought they ... Snapshot dongles contained very significant security flaws, which allowed ...
(Date:4/1/2015)... 2015 After a particularly harsh winter, many ... can lead to costly damage, so Amica Insurance ... sharing the following suggestions from AAA: , , ... be inflated to the manufacturer’s recommended levels. , ... vibration and uneven tire wear can be signs of bad ...
(Date:4/1/2015)... Baby Bellies & Beyond Baby Expo, ... on the top products and services to new and ... Records title for "Mommy Moments” - the largest gathering ... Baby Bellies & Beyond Expo Orlando on Sunday, April ... Record will commence at 11:00am with actual record counting ...
(Date:4/1/2015)... 2015 The Pennsylvania Court overseeing a ... http://www.risperdallawsuit2014.com/ ) has scheduled a meeting for April ... Court of Common Pleas, the meeting will commence at ... records indicate that the proceeding will address the progress ... users who experienced gynecomastia (male breast growth) and other ...
Breaking Medicine News(10 mins):Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 2Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 3Health News:TU-Automotive: Office of The Privacy Commissioner of Canada To Set Out Privacy Considerations Surrounding UBI Products 2Health News:TU-Automotive: Office of The Privacy Commissioner of Canada To Set Out Privacy Considerations Surrounding UBI Products 3Health News:Prepare for potholes with 7 tips from Amica Insurance 2Health News:Baby Bellies & Beyond Attempts To Break Guinness World Records For “Mommy Moments” Largest Gathering Of Pregnant Women April 19 Outside Florida Hotel & Conference Center 2Health News:Baby Bellies & Beyond Attempts To Break Guinness World Records For “Mommy Moments” Largest Gathering Of Pregnant Women April 19 Outside Florida Hotel & Conference Center 3Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 3
... CHERRY HILL, N.J., April 9 Nuvilex, Inc. ... healthcare consumer products company with a portfolio of ... that Charleston Kentrist 41 Direct, Inc. (CK41), the ... four-step acne treatment system, intends to commence sales ...
... Featuring US experts in topical dermatological drug developmentPETALUMA, ... today announced that it will hold a 1-day ... USA" June 4, 2009 at the Hilton East ... the unique problems and issues confronted during development ...
... Inc. (Nasdaq: GXDX ), a provider of personalized ... financial results for the first quarter of 2009 after closing ... A conference call hosted by President and CEO, Dr. Tina ... place on the same day at 2:00pm PDT (5:00pm EDT) ...
... MONICA, Calif., April 9 Cord Blood America, Inc. ... cell preservation company ( http://www.cordblood-america.com ... stem cells to families nationwide and internationally, said that ... a sales operation, and completed their first sale in ...
... AUHC team led by Dr. Andrew Lasser, DPh, created the operational ... organized a steering committee of prominent Turkish academic physicians and led ... strategic vision for the new Anadolu Health Center. , ... ...
... brain infection , , WEDNESDAY, April 8 (HealthDay News) -- ... the U.S. market, California-based drug maker Genentech announced Wednesday. ... U.S. health officials issued a public health advisory on ... sometimes fatal brain infection. , In a prepared release, ...
Cached Medicine News:Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 2Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 3Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 4Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 5Health News:Genoptix, Inc. to Announce First Quarter 2009 Financial Results 2Health News:Cord Blood America Announces First Storage Sale in Germany; Commitment to Expansion 2Health News:Anadolu Health Center 10 Year Award Review 2Health News:Anadolu Health Center 10 Year Award Review 3Health News:Psoriasis Drug Raptiva Pulled From U.S. Market 2Health News:Psoriasis Drug Raptiva Pulled From U.S. Market 3
... important part in achieving an optimal ... capsule formation, inflammation and suture hole ... a nonabsorbable, ePTFE suture, delivers the ... a variety of surgical specialties. Soft, ...
... or creation of a vascular access, a ... of the utmost importance in many vascular ... those seeking a high-precision tunneling instrument. The ... of twisting or kinking for more accurate ...
... Cardiovascular Patch utilizes advanced fluoropolymer ... around penetrating suture and decrease ... much as 88 percent. This ... retention, multi-directional strength and low ...
... Grafts have met the challenges of ... for exceptional performance and quality, they ... surgeons worldwide. These grafts require no ... of infection, and ensure utmost thrombectomy ...
Medicine Products: